RCUS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: RCUS Market Cap History RCUS YTD Return |
RCUS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: RCUS Market Cap History RCUS YTD Return |
RCUS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
+13.10% CAGR Mouse over chart for data details
|
RCUS Stock Price Chart |
About Arcus Biosciences Inc |
Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating cancer therapies. Co.'s products include: Domvanalimab, which is an anti-TIGIT monoclonal antibody designed to promote sustained immune activation and tumor clearance; Etrumadenant, which is a dual A2a/A2b adenosine receptor antagonist, designed to inhibit the adenosine-driven impairment of tumor-infiltrating lymphocytes and myeloid cells; AB680, which is a potent and selective small-molecule CD73 inhibitor designed to provide differential benefits relative to monoclonal antibodies; and Zimberelimab, which is Co.'s anti-PD-1 antibody that Co. in-licensed to enable the development of its combination regimens. We show 26 historical shares outstanding datapoints in our coverage of RCUS's shares outstanding history. Understanding the changing numbers of RCUS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RCUS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RCUS by allowing them to research RCUS shares outstanding history as well as any other stock in our coverage universe. |
RCUS Current Stock Quote |
Free RCUS Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
RCUS Share Performance |
Shares Outstanding Peers |
Arcus Biosciences (RCUS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RDHL Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.